The purpose of this
study was to evaluate the effects of an injectable
composite made up of calcium sulfate (CAS), fluvastatin (FS), and
atelocollagen on bone augmentation in rats. Porous structures and
compressive strength of composites were evaluated. The cumulative
release kinetics of FS were determined in vitro by a spectrophotometer.
To observe bone regeneration in vivo, five different materials (normal
saline; atelocollagen gel only; composite of CAS and atelocollagen;
composite containing 0.5% FS; and composite containing 1.0% FS) were
injected in extraction sockets and in the crania of rats. Microcomputed
tomography and histological evaluation were performed after 2, 4,
and 8 weeks of healing time. The composites had high porosity (greater
than 55%). FS kept a slow and stable release for >30 days. In vivo
results demonstrated that more new bone was formed in the FS groups
compared with the other groups, and both bone mass and bone density
had prominent increase in maxillae and crania. Resorption of the composite
was also observed for cranial tissues. In conclusion, this composite
can be applied percutaneously, without any incision. It has excellent
properties with replaceability into bone and anabolic effects for
bone formation, as well as a drug delivery system for bone formation.